Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbott, AccuLogix, acheiving, acid, Acomplia, acquiree, AdipoGenix, aggravated, appetite, arguable, ASCO, authoritative, AVEO, biomarker, blinded, burden, cAMP, Catalent, characteristic, chose, CIPLA, clerical, CMC, cohort, compulsory, coordination, counterbalance, custody, deaccelerated, debate, deconsolidate, deferral, deleting, Delhi, developmental, dismissed, DMPK, docket, edge, elapsed, elicit, elucidate, emptying, enjoy, enzyme, EORTC, evidenced, explanation, fat, Fisher, FLEX, fluorescentin, fluorouracil, folinic, Frameworkissued, grandfathered, HCC, Heath, hierarchy, HIPAA, IDF, India, Indian, ineligible, injunction, insignificant, insolvency, intermittent, invasive, IRC, Israeli, Juvista, Kettering, laid, largest, leadership, learned, leave, lived, mandated, Memorial, Meridia, midst, monetizing, mortality, mouse, Mumbai, Natco, Nepal, neuropathy, Neurosearch, nonadrenaline, noncontrolling, nonqualified, nonresectable, noradrenaline, OncoVista, Ophthotech, Orange, orderly, overallotment, overweight, parallel, pedigree, pendency, permissible, petition, PFS, phenomena, pocket, political, preempted, prejudice, premature, primate, properly, publicly, pursuit, qualitative, quantitative, RACHEL, rank, reassessment, recapitulate, recharacterized, recommenced, refurbishment, region, reintroduction, reissue, reissued, remediation, Renovo, replead, rimonabant, risky, SA, sabbatical, Shire, situhybridization, Sloan, slowdown, solidify, SPA, Spain, stable, stream, succeeding, supersede, supplementary, suppressing, suppression, surveillance, synergy, tendency, tesofensine, Teva, TGF, thePAKT, TKI, Torisel, trace, triple, truncation, trust, typographical, unavailable, undesirable, unenforceable, unlawful, unlawfully, unobservable, unpatentable, unsecured, unsuitable, usin, USPTO, vendor, Virginia, vivotumor, wait, wholly, win, ZEST
Removed:
acute, added, advisor, America, Anaderm, angiogenic, antagonism, anthracenedione, attempt, attempting, attractive, automatic, bank, bearing, binding, biotech, brain, bridge, built, Cardinal, cessation, chart, Chugai, classification, clear, clinic, Cold, colon, community, comparison, cytotoxic, decided, dental, dependant, designate, differentiate, discontinuance, documented, downturn, eliminate, enhanced, exceeded, expired, extensively, faculty, FAS, field, fill, financing, fluctuation, forecast, forecasted, formally, FSP, gastrointestinal, glycogen, greatest, guaranteed, Harbor, head, hedge, hedging, Helsinn, hormone, Horsham, IGF, induced, induction, inhibiting, instrument, insulinotropic, intervention, investigation, invoiced, jointly, kit, knowledge, led, ligand, meaningful, mediator, metabolic, modernization, modulation, molecularly, municipal, neck, nonexclusive, North, notably, novo, pain, Pennsylvania, peptide, permitted, pharmacokinetic, phosphorylase, pioneered, play, potentiation, predominantly, presently, publication, recruitment, reducing, refractory, registration, relation, reluctant, replacement, restore, retired, SAB, salt, skin, south, Spring, stromal, subsidy, sustain, Switzerland, team, thought, threshold, today, transformation, treated, typical, unamortized, unexercised, Uniondale, University, Vanderbilt, vice, vulnerable
Filing tables
Filing exhibits
- 10-K Annual report
- 10.39 EX-10.39: Letter Agreement
- 10.55 EX-10.55: Change In Control Agreement
- 10.56 EX-10.56: Consulting Agreement
- 10.57 EX-10.57: Consulting Agreement
- 10.61 EX-10.61: Compensatory Arrangements for Non-employee Directors
- 10.62 EX-10.62: Compensatory Arrangements of Executive Officers
- 21 EX-21: Subsidiaries
- 23 EX-23: Consent of KPMG LLP
- 31.1 EX-31.1: Certification
- 31.2 EX-31.2: Certification
- 32.1 EX-32.1: Certification
- 32.2 EX-32.2: Certification
Related press release
OSIP similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
OSI Pharmaceuticals, Inc.:
OSI Pharmaceuticals, Inc.:
We consent to the incorporation by reference in the registration statements on
Form S-8 (No. 333-148211, No. 333-137669, No. 333-129749, No. 333-91118, No. 333-65072, No. 333-42274, No. 333-39509, No. 333-06861, No. 33-64713 and No. 33-38443) of OSI Pharmaceuticals, Inc. and subsidiaries of our report dated February 27, 2008, relating to the consolidated balance sheets of OSI Pharmaceuticals, Inc. and subsidiaries as of December 31, 2007 and 2006, and the related consolidated statements of operations, stockholders’ equity, and cash flows, for each of the years in the three-year period ended December 31, 2007, and the effectiveness of internal control over financial reporting as of December 31, 2007, which reports appear in the December 31, 2007 Annual Report on Form 10-K of OSI Pharmaceuticals, Inc.
Form S-8 (No. 333-148211, No. 333-137669, No. 333-129749, No. 333-91118, No. 333-65072, No. 333-42274, No. 333-39509, No. 333-06861, No. 33-64713 and No. 33-38443) of OSI Pharmaceuticals, Inc. and subsidiaries of our report dated February 27, 2008, relating to the consolidated balance sheets of OSI Pharmaceuticals, Inc. and subsidiaries as of December 31, 2007 and 2006, and the related consolidated statements of operations, stockholders’ equity, and cash flows, for each of the years in the three-year period ended December 31, 2007, and the effectiveness of internal control over financial reporting as of December 31, 2007, which reports appear in the December 31, 2007 Annual Report on Form 10-K of OSI Pharmaceuticals, Inc.
As discussed in Note 15 to the consolidated financial statements, the Company adopted Statement of Financial Accounting Standards No. 158,Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plansas of December 31, 2006.
As discussed in Notes 1 and 16 to the consolidated financial statements, effective January 1, 2006, the Company adopted Statement of Financial Accounting Standards No. 123(R),Shared-Based Payment.
/s/ KPMG LLP |
Melville, New York
February 27, 2008
February 27, 2008